Effient ‘unlikely’ to takeover from Plavix
pharmafile | July 23, 2009 | News story | Research and Development, Sales and Marketing |Â Â Effient, cvÂ
Related Content
Merck diabetes drug gets CV trial boost
Merck’s diabetes drug Januvia has been given a boost following worries over side effects for …
Lilly’s Efient tipped for expanded NICE approval
Eli Lilly’s anti-platelet drug Efient has been given the nod by UK healthcare watchdog NICE …
AstraZeneca’s Brilinta delayed
AstraZeneca’s blood thinning drug Brilinta faces an extra three month delay to its review by …
